ISARIC News

IDDO and ISARIC partner to support data collection and analysis for COVID-19

IDDO and ISARIC partner to support data collection and analysis for COVID-19

In January 2020, ISARIC launched an international initiative for standardised COVID-19 clinical data collection. Over the past nine months, there has been extensive global participation, resulting in one of the world’s largest collections of comprehensive clinical data for COVID-19.

Global consortium launches new study into long-term effects of COVID-19

Global consortium launches new study into long-term effects of COVID-19

ISARIC, based at Oxford University, in collaboration with Dr Janet Scott, of the MRC-University of Glasgow’s Centre for Virus Research, has launched a longitudinal observational study to measure prevalence and risk factors of long-term health and psychosocial consequences of COVID-19.

New global covid-19 long term study launched

New global covid-19 long term study launched

The international, multi-site study is launched by ISARIC to measure prevalence and risk factors of long-term health and psychosocial consequences of COVID-19. The researchers are inviting hospitals and healthcare sites worldwide to join this new study.

A global study to determine COVID-19 health and psychosocial consequences

A global study to determine COVID-19 health and psychosocial consequences

Even as the COVID-19 pandemic enters into its ninth month, much remains unknown about the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 disease. One such area is the possible long-term consequences of SARS-CoV-2 infection and the risk factors for pathological conditions resulting from the disease.

ISARIC collaboration: New national study into the long-term health impacts of COVID-19 launched

ISARIC collaboration: New national study into the long-term health impacts of COVID-19 launched

A major UK research study into the long-term health impacts of COVID-19 on hospitalised patients, involving researchers from the University of Liverpool, has been launched. The PHOSP-COVID study has been awarded £8.4million jointly by UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR).

Newly Created: GloPID-R’s Clinical Trial Networks Working Group

Newly Created: GloPID-R’s Clinical Trial Networks Working Group

Various clinical trial networks are being funded by GloPID-R members to ensure a rapid clinical research response to epidemics. The Clinical Trial Networks Working Group (CTN WG) provides the opportunity for networks like ISARIC to meet regularly and learn about each other’s work.

Dr John Amuasi (ISARIC member) has been awarded funding!

Dr John Amuasi (ISARIC member) has been awarded funding!

As part of the response to the emergence of COVID-19, the World Health Organization Africa Regional Office (WHO/AFRO) is organising various infection, prevention and control (IPC) and critical care training activities targeted at low- and middle-income countries in Africa.

The Nuffield Department of Medicine is supporting global efforts in tackling nCoV

The Nuffield Department of Medicine is supporting global efforts in tackling nCoV

Professor Peter Horby summarizes ISARIC's recently launched international protocol which will enable investigators to manage all the data and samples they've collected.

ISARIC responding to the Wuhan novel coronavirus outbreak

ISARIC responding to the Wuhan novel coronavirus outbreak

The International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) is adapting its existing tools, designed for emerging respiratory pathogens, for the current outbreak of global significance.

New Statement on Data Sharing signed by ISARIC

New Statement on Data Sharing signed by ISARIC

ISARIC has signed a new statement on sharing research findings and data relevant to the Ebola outbreak in the Democratic Republic of Congo. Anyone interested in signing should get in touch with Katherine Littler (K.Littler@wellcome.ac.uk) directly.

NEW ISARIC’s members publication: The hidden burden of influenza

NEW ISARIC’s members publication: The hidden burden of influenza

A review of the extra-pulmonary complications of influenza infection.

Ebola_CP Trial: First plasma donated by survivors in Sierra Leone

Ebola_CP Trial: First plasma donated by survivors in Sierra Leone

First Ebola survivors in Sierra Leone have donated plasma within the Ebola_CP trial led by Calum Semple (ISARIC WG2 Chair) and a team of scientists at the University of Liverpool and the College of Medicine and Allied Health Services, in Sierra Leone.